Dr. Pecora on How MACRA Needs Fine Tuning

Andrew L. Pecora, MD
Published: Friday, Aug 12, 2016


Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, talked about the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and other aspects of healthcare reform.

MACRA is a well-intentioned law, but it’s highly complex and it is designed to take the practice of medicine to another level. That’s all very well and good, says Pecora, but when you come down to it, how much time is there in the physician’s day to adapt to the many administrative duties that will be imposed upon his or her office as a result of this reform?

Doctors are lucky if they have enough time to sit down and enjoy lunch. Furthermore, patients show up at all hours with maladies that cannot wait. It’s the doctor’s duty to address those concerns first. The MACRA priorities don’t seem to reflect those types of concerns. Therefore, the fact that CMS is considering slowing down the program and taking some of the pressure off physicians is a good thing, Pecora says.

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, talked about the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) and other aspects of healthcare reform.

MACRA is a well-intentioned law, but it’s highly complex and it is designed to take the practice of medicine to another level. That’s all very well and good, says Pecora, but when you come down to it, how much time is there in the physician’s day to adapt to the many administrative duties that will be imposed upon his or her office as a result of this reform?

Doctors are lucky if they have enough time to sit down and enjoy lunch. Furthermore, patients show up at all hours with maladies that cannot wait. It’s the doctor’s duty to address those concerns first. The MACRA priorities don’t seem to reflect those types of concerns. Therefore, the fact that CMS is considering slowing down the program and taking some of the pressure off physicians is a good thing, Pecora says.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x